Patient Guide: Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 25 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03598608
Status: ACTIVE_NOT_RECRUITING
Condition: Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 25 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Gilbert, Arizona
  • Duarte, California
  • Los Angeles, California
  • • And 22 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily